Annual ROE
-86.15%
+21.01%+19.61%
31 December 2023
Summary:
Sarepta Therapeutics annual return on equity is currently -86.15%, with the most recent change of +21.01% (+19.61%) on 31 December 2023. During the last 3 years, it has fallen by -16.00% (-22.81%). SRPT annual ROE is now -857.22% below its all-time high of -9.00%, reached on 31 December 2017.SRPT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
12.48%
+7.11%+132.40%
30 September 2024
Summary:
Sarepta Therapeutics quarterly return on equity is currently 12.48%, with the most recent change of +7.11% (+132.40%) on 30 September 2024. Over the past year, it has increased by +126.32% (+110.96%). SRPT quarterly ROE is now at all-time high.SRPT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.6% | +111.0% |
| 3 y3 years | -22.8% | +116.1% |
| 5 y5 years | -116.8% | +120.6% |
SRPT ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.8% | +19.6% | at high | +107.0% |
| 5 y | 5 years | -116.8% | +19.6% | at high | +107.0% |
| alltime | all time | -857.2% | +72.1% | at high | +102.9% |
Sarepta Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 12.48%(+132.4%) |
| June 2024 | - | 5.37%(+156.9%) |
| Mar 2024 | - | 2.09%(-102.7%) |
| Dec 2023 | -86.15%(-19.6%) | -77.39%(-32.0%) |
| Sept 2023 | - | -113.84%(-24.8%) |
| June 2023 | - | -151.46%(-15.5%) |
| Mar 2023 | - | -179.19%(+69.5%) |
| Dec 2022 | -107.16%(+116.2%) | -105.72%(+0.7%) |
| Sept 2022 | - | -104.97%(+43.6%) |
| June 2022 | - | -73.09%(+34.3%) |
| Mar 2022 | - | -54.44%(-17.3%) |
| Dec 2021 | -49.57%(-29.3%) | -65.85%(-14.8%) |
| Sept 2021 | - | -77.31%(-9.4%) |
| June 2021 | - | -85.34%(+6.1%) |
| Mar 2021 | - | -80.41%(+35.2%) |
| Dec 2020 | -70.15%(-9.2%) | -59.46%(-3.1%) |
| Sept 2020 | - | -61.36%(+18.0%) |
| June 2020 | - | -51.99%(-14.3%) |
| Mar 2020 | - | -60.67%(-10.2%) |
| Dec 2019 | -77.29%(+94.5%) | -67.54%(+11.4%) |
| Sept 2019 | - | -60.63%(+2.5%) |
| June 2019 | - | -59.18%(+32.0%) |
| Mar 2019 | - | -44.83%(-2.5%) |
| Dec 2018 | -39.74%(+341.6%) | -45.96%(+35.1%) |
| Sept 2018 | - | -34.01%(+5.0%) |
| June 2018 | - | -32.39%(+16.9%) |
| Mar 2018 | - | -27.71%(+187.4%) |
| Dec 2017 | -9.00%(-91.1%) | -9.64%(-62.3%) |
| Sept 2017 | - | -25.59%(-31.0%) |
| June 2017 | - | -37.09%(-13.7%) |
| Mar 2017 | - | -43.00%(-61.5%) |
| Dec 2016 | -101.42%(+0.9%) | -111.73%(-9.8%) |
| Sept 2016 | - | -123.90%(-23.2%) |
| June 2016 | - | -161.41%(+21.1%) |
| Mar 2016 | - | -133.29%(+12.4%) |
| Dec 2015 | -100.47%(+83.1%) | -118.63%(+21.5%) |
| Sept 2015 | - | -97.62%(+32.3%) |
| June 2015 | - | -73.78%(+10.3%) |
| Mar 2015 | - | -66.91%(+29.1%) |
| Dec 2014 | -54.88%(-9.1%) | -51.83%(+35.5%) |
| Sept 2014 | - | -38.26%(-24.7%) |
| June 2014 | - | -50.81%(-6.9%) |
| Mar 2014 | - | -54.59%(-22.6%) |
| Dec 2013 | -60.39%(-61.5%) | -70.52%(-53.7%) |
| Sept 2013 | - | -152.37%(-44.0%) |
| June 2013 | - | -271.87%(-9.3%) |
| Mar 2013 | - | -299.83%(-7.7%) |
| Dec 2012 | -156.81%(+853.8%) | -324.90%(+1.5%) |
| Sept 2012 | - | -320.03%(+470.1%) |
| June 2012 | - | -56.14%(-42.0%) |
| Mar 2012 | - | -96.82%(+702.2%) |
| Dec 2011 | -16.44%(-94.7%) | -12.07%(-80.5%) |
| Sept 2011 | - | -61.82%(-52.1%) |
| June 2011 | - | -128.94%(-70.4%) |
| Mar 2011 | - | -435.34%(+53.9%) |
| Dec 2010 | -309.20% | -282.80%(+113.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -132.61%(-4.1%) |
| June 2010 | - | -138.29%(+4.0%) |
| Mar 2010 | - | -133.02%(-9.5%) |
| Dec 2009 | -127.83%(+12.4%) | -147.06%(-22.8%) |
| Sept 2009 | - | -190.57%(+9.7%) |
| June 2009 | - | -173.66%(+241.4%) |
| Mar 2009 | - | -50.86%(-57.3%) |
| Dec 2008 | -113.75%(+34.2%) | -119.20%(-11.5%) |
| Sept 2008 | - | -134.73%(+4.1%) |
| June 2008 | - | -129.47%(-12.3%) |
| Mar 2008 | - | -147.63%(+35.0%) |
| Dec 2007 | -84.78%(+24.7%) | -109.38%(-1.2%) |
| Sept 2007 | - | -110.71%(+25.8%) |
| June 2007 | - | -88.00%(+23.0%) |
| Mar 2007 | - | -71.54%(+12.8%) |
| Dec 2006 | -68.01%(+63.0%) | -63.45%(+14.3%) |
| Sept 2006 | - | -55.52%(+17.7%) |
| June 2006 | - | -47.19%(+6.6%) |
| Mar 2006 | - | -44.26%(+5.6%) |
| Dec 2005 | -41.73%(-41.3%) | -41.91%(-13.6%) |
| Sept 2005 | - | -48.53%(-17.1%) |
| June 2005 | - | -58.55%(-7.5%) |
| Mar 2005 | - | -63.27%(-8.2%) |
| Dec 2004 | -71.14%(+62.8%) | -68.94%(+13.4%) |
| Sept 2004 | - | -60.78%(+6.2%) |
| June 2004 | - | -57.22%(+9.6%) |
| Mar 2004 | - | -52.23%(+14.1%) |
| Dec 2003 | -43.71%(-59.8%) | -45.76%(-16.1%) |
| Sept 2003 | - | -54.57%(-14.4%) |
| June 2003 | - | -63.73%(-27.0%) |
| Mar 2003 | - | -87.27%(-8.5%) |
| Dec 2002 | -108.71%(+29.0%) | -95.42%(+3.1%) |
| Sept 2002 | - | -92.55%(-16.4%) |
| June 2002 | - | -110.77%(+18.7%) |
| Mar 2002 | - | -93.32%(+12.3%) |
| Dec 2001 | -84.27%(+106.4%) | -83.07%(+11.7%) |
| Sept 2001 | - | -74.40%(+86.2%) |
| June 2001 | - | -39.95%(-9.9%) |
| Mar 2001 | - | -44.32%(+5.8%) |
| Dec 2000 | -40.83%(-48.6%) | -41.88%(-22.3%) |
| Sept 2000 | - | -53.92%(-41.4%) |
| June 2000 | - | -91.97%(+1.3%) |
| Mar 2000 | - | -90.79%(-19.9%) |
| Dec 1999 | -79.43%(-59.4%) | -113.39%(-1.4%) |
| Sept 1999 | - | -114.96%(-59.4%) |
| June 1999 | - | -283.06%(+25.5%) |
| Mar 1999 | - | -225.46%(+19.6%) |
| Dec 1998 | -195.60%(+503.1%) | -188.47%(+20.7%) |
| Sept 1998 | - | -156.13%(+465.3%) |
| June 1998 | - | -27.62%(-10.0%) |
| Mar 1998 | - | -30.68%(+27.1%) |
| Dec 1997 | -32.43%(-39.8%) | -24.13%(+17.1%) |
| Sept 1997 | - | -20.60%(+14.6%) |
| June 1997 | - | -17.98%(-88.0%) |
| Mar 1997 | - | -150.00% |
| Dec 1996 | -53.85% | - |
FAQ
- What is Sarepta Therapeutics annual return on equity?
- What is the all time high annual ROE for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual ROE year-on-year change?
- What is Sarepta Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly ROE year-on-year change?
What is Sarepta Therapeutics annual return on equity?
The current annual ROE of SRPT is -86.15%
What is the all time high annual ROE for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual return on equity is -9.00%
What is Sarepta Therapeutics annual ROE year-on-year change?
Over the past year, SRPT annual return on equity has changed by +21.01% (+19.61%)
What is Sarepta Therapeutics quarterly return on equity?
The current quarterly ROE of SRPT is 12.48%
What is the all time high quarterly ROE for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly return on equity is 12.48%
What is Sarepta Therapeutics quarterly ROE year-on-year change?
Over the past year, SRPT quarterly return on equity has changed by +126.32% (+110.96%)